Biosimilars Market Industry Share, Size: 2021 Market Research with Growth, Segments and Forecast - 2027


Posted September 28, 2021 by danishahmed

The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a CAGR of 49% during the forecast period 2021 to 2027.
 
The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a CAGR of 49% during the forecast period 2021 to 2027.
Biosimilars are biological medical products that are very similar to other biological medicines that have already been approved. Biosimilars are approved under the same pharmaceutical quality, safety, and efficacy standards that apply to all biological drugs. The global biosimilar market is driven by factors such as cost-effectiveness and increasing demand for biosimilars due to the spread of chronic diseases. In addition, the pressure to reduce healthcare expenditures, along with the expiration of patents for various blockbuster drugs and increased approval of biosimilar drugs by the FDA, is expected to accelerate market growth.



(Get 15% Discount on Buying this Report)
Get Sample at: https://www.orionmarketreports.com/request-sample/?id=53530

Market Segments

Key Players

Pfizer (US),
Sandoz (Germany),
Biocon (India), Biogen (US),
Fresenius Kabi AG (Germany),
Boehringer Ingelheim (Germany),
Merck KgaA (Germany),
Mylan (US),
Eli Lilly (US),
Teva Pharmaceutical (Israel),
Dr. Reddy’s Laboratories (India),
Amgen (US),
Celltrion (South Korea),
Samsung Biologics (South Korea)
Amega Biotech (Argentina)
mAbxience (Switzerland),
Probiomed (Mexico)
 Apotex (Canada),
Chong Kun Dang (South Korea),

By Types

Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others

By Applications

Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others






A full report is available at : https://www.orionmarketreports.com/biosimilars-market/53530/
Scope of the Heart
The research study analyzes the global Biosimilars industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

For more customized data, request for report customization @ https://www.orionmarketreports.com/inquiry-before-buying/?id=53530
About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Danish Ahmed
Phone +917803040404
Country India
Categories Business
Last Updated September 28, 2021